1. Home
  2. VYX vs ANIP Comparison

VYX vs ANIP Comparison

Compare VYX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYX
  • ANIP
  • Stock Information
  • Founded
  • VYX 1881
  • ANIP 2001
  • Country
  • VYX United States
  • ANIP United States
  • Employees
  • VYX N/A
  • ANIP N/A
  • Industry
  • VYX
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • VYX
  • ANIP Health Care
  • Exchange
  • VYX Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • VYX 1.8B
  • ANIP 2.0B
  • IPO Year
  • VYX N/A
  • ANIP N/A
  • Fundamental
  • Price
  • VYX $12.19
  • ANIP $90.89
  • Analyst Decision
  • VYX Buy
  • ANIP Strong Buy
  • Analyst Count
  • VYX 6
  • ANIP 8
  • Target Price
  • VYX $15.17
  • ANIP $93.63
  • AVG Volume (30 Days)
  • VYX 1.1M
  • ANIP 326.2K
  • Earning Date
  • VYX 11-06-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • VYX N/A
  • ANIP N/A
  • EPS Growth
  • VYX N/A
  • ANIP N/A
  • EPS
  • VYX 7.32
  • ANIP N/A
  • Revenue
  • VYX $2,677,000,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • VYX N/A
  • ANIP $39.36
  • Revenue Next Year
  • VYX N/A
  • ANIP $9.45
  • P/E Ratio
  • VYX $1.67
  • ANIP N/A
  • Revenue Growth
  • VYX N/A
  • ANIP 38.68
  • 52 Week Low
  • VYX $7.55
  • ANIP $52.50
  • 52 Week High
  • VYX $15.34
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • VYX 39.50
  • ANIP 46.49
  • Support Level
  • VYX $12.39
  • ANIP $88.19
  • Resistance Level
  • VYX $13.02
  • ANIP $92.52
  • Average True Range (ATR)
  • VYX 0.33
  • ANIP 2.59
  • MACD
  • VYX -0.05
  • ANIP -1.05
  • Stochastic Oscillator
  • VYX 3.85
  • ANIP 25.72

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: